Given the fact that drug & alcohol addictions, as well as mental health and co-occurring disorders, are such debilitating factors within modern day society, especially in light on the recent opioid epidemic nationwide, Recovery House 54 feels it to be very necessary to present an entire page highlighting the most recent news & articles industry-wide. We have essentially created what are called “RSS Feeds” and designed them to pull the most recent articles from two well regarded news outlets within the realms of substance abuse and mental health, those being: NIDA (National Institute on Drug Abuse) and Science Daily.
Please note that the articles and information shown below are generally going to be unbiased and factual, although there may be exceptions from time to time. An example of this may be, for instance, a press release issued by a drug rehab center that for whatever reason was picked up and published by one of the news outlets below. As such, Recovery House 54 does not officially endorse nor has any opinion on the information displayed. However, from our experience over the years, both NIDA and Science Daily have historically shown themselves to be trustworthy and unbiased sources.
National Institute on Drug Abuse (NIDA)
NIDA News
A 14-year-old’s innovative approach to prevent tampering and misuse of opioid pills won a first place Addiction Science Award at the 2019 Intel International Science and Engineering Fair (ISEF)—the world’s largest science competition for high school students. The awards are...
Posted: May 17, 2019, 12:00 am
The National Institute on Drug Abuse (NIDA) Intramural Research Program will hold a one-day symposium to summarize the most recent advances in opioid research. Topics range from the use of a therapeutic workplace to address opioid use disorders to basic research such as findings...
Posted: May 15, 2019, 12:00 am
Photo by ©iStock.com/dptulk
As health care providers lower opioid doses for pain patients to minimize the risk of addiction; increase doses to manage worsening pain; or re-start dosing after a period of time without opioid pain relievers, patients could be getting confused about safe...
Posted: April 22, 2019, 12:00 am
Scientists are working to develop medicines that have the pain-relieving effects of opioids without the high risk of misuse and addiction. Since misuse is linked to the euphoric effects of the drug, investigators led by scientists at NIDA’s intramural labs are studying methadone, a drug...
Posted: March 26, 2019, 12:00 am
Jack B. Stein, Ph.D.
Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), has appointed Jack B. Stein, Ph.D., to be the NIDA Chief of Staff, a newly created position to support and assist the Director with coordination and strategic planning of key institute initiatives....
Posted: March 20, 2019, 12:00 am
Science Daily
Addiction News -- ScienceDaily
Read current medical research articles on drug addition including nicotine, prescription drugs and illegal drugs. Find out about addiction treatment.
The legalization of recreational marijuana is associated with an increase in its abuse, injury due to overdoses, and car accidents, but does not significantly change health care use overall, according to a new study.
Posted: May 15, 2019, 3:03 pm
Surgical patients receiving the opioid tramadol have a somewhat higher risk of prolonged use than those receiving other common opioids, new research finds. However, the Drug Enforcement Administration (DEA) classifies tramadol as a Schedule IV controlled substance, meaning it's considered to have a lower risk of addiction and abuse than Schedule II opioids, such as oxycodone and hydrocodone.
Posted: May 14, 2019, 1:09 pm
Regular coffee drinkers can sniff out even tiny amounts of coffee and are faster at recognizing the aroma, which could open the door to new ways of using aversion therapy for addiction.
Posted: May 14, 2019, 12:17 pm
Postpartum women who have previously or currently struggle with substance abuse are at greater risk of overdosing.
Posted: May 9, 2019, 12:00 pm
A new study found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario. The study also found that the longer the brand-name prescription drug was on the market, the greater the price differential.
Posted: May 6, 2019, 8:07 pm
